See the DrugPatentWatch profile for Lacosamide
Lacosamide is classified as an anticonvulsant or anti-epileptic drug. It is prescribed to treat partial-onset seizures in individuals with epilepsy. [1]
How does lacosamide work to control seizures?
Lacosamide's exact mechanism of action in controlling seizures is not fully understood. However, it is believed to selectively enhance the slow inactivation of voltage-gated sodium channels. This action is thought to reduce the repetitive firing of neurons that can lead to seizures. [2]
What are the common dosages and administration of lacosamide?
Lacosamide is available in various formulations, including oral tablets, oral solution, and intravenous solution. The starting dose for adults is typically 50 mg twice daily, which can be increased to a target maintenance dose of 100-200 mg twice daily. The maximum recommended daily dose is 400 mg. Dosing may need to be adjusted for patients with severe renal or hepatic impairment. [1]
When does lacosamide patent exclusivity expire?
Information on specific patent expiry dates for lacosamide can be found through specialized patent databases. [3]
What are the potential side effects of lacosamide?
Common side effects associated with lacosamide use include dizziness, headache, nausea, vomiting, fatigue, and diplopia (double vision). Less common but more serious side effects can include suicidal thoughts, mood changes, and allergic reactions. [1]
Are there alternative medications for partial-onset seizures?
Yes, several other medications are available to treat partial-onset seizures, including levetiracetam, carbamazepine, and lamotrigine. The choice of medication depends on individual patient factors, seizure type, and response to treatment. [4]
How does lacosamide compare to other anti-epileptic drugs?
Lacosamide's unique mechanism of action, targeting slow inactivation of sodium channels, differentiates it from some other anti-epileptic drugs. Its efficacy and side effect profile are considered when choosing a treatment. [2]
What are the regulatory considerations for lacosamide?
Lacosamide is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for the treatment of partial-onset seizures. Manufacturers must adhere to strict manufacturing and quality control standards. [1]
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/